Protease inhibitors on trial for inflammatory bowel disease.
Bonn
D
D
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D014358:Trypsin Inhibitor, Bowman-Birk Soybean / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D014358:Trypsin Inhibitor, Bowman-Birk Soybean